Swissmedic
Federal · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Hallerstrasse 7, Bern, Bern, 3012, Switz...Phone Number
+41 584620211Website
www.swissmedic.chRevenue
$113.8 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
3
2
2
About Swissmedic
Swissmedic is the Swiss Agency for Therapeutic Products responsible for the authorization and supervision of therapeutic products in Switzerland. The agency ensures that all medicines and medical devices available in the Swiss market are effective, safe, and of high quality. Its intended clients include healthcare professionals, patients, and companies involved in the pharmaceutical and medical device sectors. Swissmedic also provides guidance on regulatory compliance and monitors safety measures related to therapeutic products.Explore more
Swissmedic Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Swissmedic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Swissmedic has new funding data
Congratulate Masked Content for being promoted to Masked Content at Swissmedic
Check out if Swissmedic is spiking on competitors!
Check if Swissmedic has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Swissmedic recently announced quarterly report
Swissmedic, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Swissmedic launches new products
Click to see if Swissmedic had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Swissmedic as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Swissmedic is experiencing very low activity levels compared to other companies in the Government sector.
What does this means?
Swissmedic is drawing exceptional interest within the Government industry, suggesting notable developments or strong market momentum, learn more about Swissmedic.
Swissmedic Tech Stack
A closer look at the technologies used by Swissmedic
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Event
Product Marketing, Events, Sales, Compliance, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Open Position
Swissmedic News & Media
Novartis receives approval for first malaria medicine for newborn babies and young infants
Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.Swissmedic To Facilitate Exchanges With Companies Under Digital Transformation Drive
The Swiss health care products agency said the digital platforms it was building for processes relating to approvals, authorizations and market surveillance aimed to make data management faster and more targeted.Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
-- Amarin Continuing Process for Obtaining National Pricing and Reimbursement in Switzerland in the Course of 2023 -- -- Swissmedic Approval Underpins Company’s Presence and Expansion in Switzerland as its Regional Commercial Hub for Europe --Hansa Biopharma announces temporary marketing authorization in Switzerland for Idefirix[®] (imlifidase) in kidney transplantation
· Approval by Swissmedic[1] enables highly sensitized patients in Switzerland to receive Idefirix[®] treatment prior to kidney transplantation · Idefirix[®] is now granted marketing authorization within the EU, the U.K.*, Israel and Switzerland Lund, Sweden May 13, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, today announces that the Swiss Agency for Therapeutic Products (Swissmedic) has granted temporary marketing au
Read more news
Top Federal Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Swissmedic
Sign Up For FreeTo access detailed company insights
Swissmedic is the Swiss Agency for Therapeutic Products responsible for the authorization and supervision of therapeutic products in Switzerland. The agency ensures that all medicines and medical devices available in the Swiss market are effective, safe, and of high quality. Its intended clients include healthcare professionals, patients, and compa... Read More
